Clinical Risk Acknowledgement, Assumption of Professional Responsibility, Limited Release, Covenant not to Sue, and Third-party Indemnification Agreement
IMPORTANT—LEGALLY BINDING CHECKOUT AGREEMENT
Review this Agreement carefully before purchasing. It affects legal rights, allocates responsibility for independent clinical conduct, and contains a limited release, covenant not to sue, and third-party indemnification obligation. Checking the required box at checkout constitutes your affirmative electronic acceptance of the entire Agreement. Do not check the box or complete the purchase if you do not understand or agree to every provision.
Purchase and access to clinical course content are conditioned on accepting this Agreement through the required checkout checkbox.
1. Parties, Scope, and Purpose
This Clinical Risk Acknowledgment, Assumption of Professional Responsibility, Limited Release, Covenant Not to Sue, and Third-Party Indemnification Agreement (the “Agreement”) is entered into between MBR Hunt LLC, doing business as The French Academy of Advanced Aesthetics and The French NP (the “Académie”, "Academy"), and the individual professional who affirmatively accepts this Agreement through the required checkbox associated with the purchaser’s Academy account and order (“Student”).
“Academy Parties” means the Academy and its current and former owners, members, managers, officers, employees, instructors, presenters, contractors, affiliates, agents, successors, and assigns, including Sandy L. Hunt, AGACNP-C, solely in their capacities relating to Academy content or operations.
This Agreement applies to all Academy online courses, videos, demonstrations, lessons, downloads, presentations, case discussions, community content, and related communications that contain clinical, procedural, injectable, off-label, device-based, regenerative, or other medical-aesthetic education (collectively, “Clinical Content”). It is a material condition of purchasing, receiving, or accessing Clinical Content.
“Academy Parties” means the Academy and its current and former owners, members, managers, officers, employees, instructors, presenters, contractors, affiliates, agents, successors, and assigns, including Sandy L. Hunt, AGACNP-C, solely in their capacities relating to Academy content or operations.
2. Professional Eligibility and Student Respresentations
Student represents and warrants, as of checkbox acceptance and throughout access, that Student:
- is the individual enrolling and will not share an account, credential, or Clinical Content with any other person;
- holds a current, active, and unrestricted professional license appropriate for the purchased course, and has supplied complete and accurate credential information;
- will independently verify that receiving and applying the education is permitted for Student’s license, role, facility, and jurisdiction;
- is not relying on the Academy to determine Student’s scope of practice, legal authority, competency, credentialing, supervision, or insurance coverage; and
- will promptly notify the Academy if Student’s license is restricted, suspended, surrendered, expired, or otherwise materially changes during course access.
The Academy may verify credentials, request additional
documentation, withhold or suspend access, and enforce its eligibility
requirements. Credential review by the Academy is administrative only and is
not a determination that any procedure is within Student’s scope or competence.
3. Professional Education Only; No Clinical Relationship
Clinical Content is general professional education. It is not medical advice for any particular patient; not a patient-specific treatment plan; not a prescription, order, protocol, standard of care, or emergency consultation; and not legal, regulatory, credentialing, billing, coding, or insurance advice.
Purchase, viewing, completion, questions, or support communications do not create an instructor–student clinical-supervision relationship, preceptorship, mentorship, consultation arrangement, physician–patient or provider–patient relationship, duty to treat, duty to monitor, or other fiduciary or professional relationship. The Academy does not assume responsibility for Student’s patients, clinical practice, employer, facility, or professional acts or omissions.
4. Off-label, Investigational, and Evolving Information
Clinical Content may discuss or demonstrate:
Inclusion in Clinical Content is not a representation, warranty, endorsement, directive, or recommendation that the approach is safe, effective, appropriate, lawful, within Student’s scope, reimbursable, or suitable for any patient. FDA approval of a product for one use does not mean FDA has determined the product is safe or effective for an off-label use.
- use of an FDA-approved drug or FDA-approved or FDA-cleared device outside its approved or cleared labeling (“off-label use”);
- a treatment location, indication, patient population, dose, dilution, route, depth, plane, sequence, combination, preparation, or technique not included in current labeling or instructions for use;
- a product, device, preparation, technique, or treatment approach that is investigational, not approved or cleared for the discussed use, unavailable in a jurisdiction, or subject to differing interpretations or evolving evidence; and
- techniques that are lawful for some professionals or jurisdictions but restricted or prohibited for others.
Inclusion in Clinical Content is not a representation, warranty, endorsement, directive, or recommendation that the approach is safe, effective, appropriate, lawful, within Student’s scope, reimbursable, or suitable for any patient. FDA approval of a product for one use does not mean FDA has determined the product is safe or effective for an off-label use.
Labeling, warnings, contraindications, instructions for use, recalls, safety communications, regulatory status, evidence, professional guidance, and standards of care may change after recording or publication. The Academy does not promise that recorded content will remain current. Before every clinical decision, Student must consult current primary and authoritative sources, including current manufacturer labeling and instructions for use, safety communications, applicable law, licensing-board guidance, facility rules, and relevant evidence.
5. Online Education Does Not Establish Competency
Watching, studying, completing, or receiving a certificate, when applicable, for Clinical Content does not:
A certificate of completion, if issued, documents only that the platform’s stated completion criteria were met. It is not board certification, professional certification, licensure, credentialing, a competency determination, or authorization to perform a procedure. Unless a course page expressly states otherwise, the course does not award CME or CE credit.
- constitute hands-on clinical training, supervised practice, proctoring, preceptorship, or verified clinical experience;
- establish, assess, or verify competence, proficiency, readiness, or safety to perform any procedure;
- grant or expand any license, certification, credential, privilege, prescribing authority, ordering authority, or scope of practice;
- satisfy any legally, professionally, or institutionally required education, supervision, credentialing, continuing-education, or competency requirement unless expressly stated in writing by the Academy and independently accepted by the applicable authority; or
- replace anatomy education, cadaver education where appropriate, supervised hands-on training, complication-management training, emergency preparation, or documented competency assessment.
A certificate of completion, if issued, documents only that the platform’s stated completion criteria were met. It is not board certification, professional certification, licensure, credentialing, a competency determination, or authorization to perform a procedure. Unless a course page expressly states otherwise, the course does not award CME or CE credit.
6. Conditions Before Any Clinical Application
Student will not attempt, adopt, teach, supervise, delegate, or apply a demonstrated procedure or technique unless Student first:
- holds every required license, certification, registration, prescribing or ordering authority, facility credential, and clinical privilege;
- confirms compliance with all laws, regulations, board rules, facility policies, supervision or collaboration requirements, and professional standards in the place of practice;
- obtains sufficient current, anatomy-based, supervised hands-on and complication-management training from qualified professionals;
- possesses the necessary knowledge, technical skill, experience, judgment, and patient-selection capability;
- reviews current labeling, instructions for use, contraindications, warnings, precautions, preparation and storage requirements, recalls, and regulatory status;
- performs an independent patient-specific history, examination, risk assessment, differential assessment where relevant, and treatment plan;
- obtains legally and professionally sufficient informed consent that is specific to the patient, product, device, procedure, alternatives, off-label status where applicable, and reasonably foreseeable risks;
- has appropriate documentation, infection-control systems, trained support, emergency protocols, medications, reversal agents where applicable, supplies, equipment, transfer capability, referral relationships, and timely follow-up resources;
- has a plan and present capability to recognize, evaluate, stabilize, manage, document, disclose, report, refer, and follow complications without relying on the Academy; and
- maintains professional-liability and other insurance appropriate for the procedure, off-label use where applicable, location, and scope of practice, and confirms that no policy exclusion defeats coverage.
7. Serious, Permanent, and Potentially Fatal Risks
Medical-aesthetic procedures can cause unexpected, serious, permanent, disfiguring, life-altering, or fatal complications even when performed by experienced professionals and even when precautions are used. Risks vary by patient, anatomy, product, device, technique, location, dose, preparation, sequence, and combination. Risks include, without limitation:
FDA identifies unintentional injection of dermal filler into a blood vessel as the most concerning filler-related risk and reports that complications can include tissue necrosis, vision abnormalities including blindness, and stroke. No educational program, injection technique, needle or cannula selection, aspiration practice, ultrasound use, anatomical landmark, protocol, or precaution can eliminate all procedural risk.
- General procedural risks: pain, bruising, bleeding, hematoma, edema, inflammation, infection, biofilm, scarring, pigment change, contour irregularity, asymmetry, poor wound healing, allergic or hypersensitivity reaction, delayed inflammatory reaction, unsatisfactory result, need for correction, and worsening of an underlying condition;
- Filler and biostimulator risks: intravascular injection, vascular occlusion, embolization, ischemia, skin or soft-tissue necrosis, permanent scarring, retinal or ophthalmic artery injury, visual disturbance, partial or total blindness, cerebral ischemia or hemorrhage, stroke, neurological injury, paralysis, nodules, granulomas, migration, calcification, delayed reactions, and death;
- Neurotoxin risks: eyelid or brow ptosis, diplopia, dry eye, facial weakness, asymmetry, unintended muscle paralysis, dysarthria, dysphonia, dysphagia, aspiration, breathing difficulty, systemic or distant spread of toxin effect, botulism-like symptoms, hospitalization, and death;
- Blood-derived or regenerative procedure risks: phlebotomy injury, vasovagal reaction, hematoma, contamination, infection, needlestick or blood exposure, processing or device error, clotting or embolic events, injection-related vascular injury, inflammatory reaction, and unpredictable or inadequate results;
- Needle, cannula, and subcision risks: injury to a vessel, nerve, muscle, gland, duct, fascia, periosteum, or other structure; perforation; significant bleeding; hematoma; infection; pain; fibrosis; tethering; sensory or motor deficit; and scarring;
- Device and energy-based risks: burns, blistering, pigment alteration, scarring, fat loss, tissue loss, disfigurement, nerve injury, ocular injury, electrical or mechanical injury, infection, and the need for medical or surgical repair;
- Medication and anesthetic risks: toxicity, drug interaction, dosing or dilution error, allergic reaction, anaphylaxis, altered sensation, cardiac or neurologic effects, airway compromise, and death;
- Combination and unknown risks: additive, cumulative, delayed, interacting, emerging, or presently unknown complications, including risks not established for an off-label or unapproved use; and
- Consequences of complications: emergency treatment, reversal attempts, specialist care, transfer, hospitalization, surgery, prolonged treatment, permanent disability, professional-board or regulatory reporting, financial loss, litigation, or death.
FDA identifies unintentional injection of dermal filler into a blood vessel as the most concerning filler-related risk and reports that complications can include tissue necrosis, vision abnormalities including blindness, and stroke. No educational program, injection technique, needle or cannula selection, aspiration practice, ultrasound use, anatomical landmark, protocol, or precaution can eliminate all procedural risk.
8. Independent Clinical Responsibility
Student retains exclusive responsibility for all professional and clinical decisions and conduct, including whether to treat; patient selection; diagnosis and assessment; product sourcing and authenticity; storage and preparation; product, dose, dilution, device, setting, depth, plane, technique, sequence, and combination; informed consent; delegation and supervision; infection control; documentation; photography; privacy; post-procedure instructions; follow-up; complication recognition and management; emergency response; referral; mandatory reporting; and compliance with law and professional standards.
Student will not present Clinical Content, an instructor’s statements, or a certificate, if issued, as patient-specific approval, a standard of care, proof of competency, or a substitute for Student’s own documented judgment. Student will not submit patient-identifying information through general Academy email, community, comments, or technical-support channels and will not rely on an Academy response—or the absence of a response—in an urgent or emergent situation.
9. Knowing Assumptions of Professional Responsibility and Risk
To the fullest extent permitted by law, Student knowingly and voluntarily assumes all professional, clinical, regulatory, financial, reputational, and legal risks arising from or relating to Student’s decision to use, adapt, teach, supervise, delegate, or apply Clinical Content in Student’s own practice, including the risks described in this Agreement and risks that are not currently known or foreseeable. Student understands that enrollment is voluntary and that Student may decline to purchase or access Clinical Content.
10. Limited Release of Student's Claims
TO THE FULLEST EXTENT PERMITTED BY LAW, STUDENT RELEASES AND DISCHARGES THE ACADEMY PARTIES FROM CLAIMS, DEMANDS, CAUSES OF ACTION, DAMAGES, LOSSES, COSTS, AND EXPENSES BROUGHT BY OR THROUGH STUDENT THAT ARISE FROM OR RELATE TO: (A) STUDENT’S INDEPENDENT CLINICAL USE, ADAPTATION, PERFORMANCE, TEACHING, SUPERVISION, DELEGATION, OR MISUSE OF CLINICAL CONTENT; (B) A PATIENT-SPECIFIC DECISION OR OUTCOME; (C) A COMPLICATION ARISING FROM STUDENT’S PROFESSIONAL SERVICES; OR (D) STUDENT’S FAILURE TO SATISFY THE CONDITIONS IN THIS AGREEMENT. WITHIN THAT LIMITED SCOPE, THIS RELEASE INCLUDES CLAIMS ALLEGING ORDINARY NEGLIGENCE BY AN ACADEMY PARTY IN THE CREATION, SELECTION, PRESENTATION, OR COMMUNICATION OF CLINICAL CONTENT.
This release does not apply to the extent a claim is finally determined to result from an Academy Party’s gross negligence, reckless or willful misconduct, intentional wrongdoing, or fraud; to a claim that cannot lawfully be released; or to a contractual refund or access remedy expressly preserved by the Refund, Cancellation, and Course Access Policy. Nothing in this Agreement waives a mandatory statutory right that cannot lawfully be waived.
11. Limited Covenant Not to Sue
Student agrees not to commence, maintain, finance, assist, or voluntarily participate in a claim against an Academy Party that falls within the release in Section 10. This covenant does not prevent Student from responding truthfully to lawful process, communicating with a regulator, reporting a safety concern, exercising a nonwaivable right, or pursuing a claim expressly excluded from Section 10. If a court determines that part of this covenant is unenforceable, it shall be enforced to the maximum lawful extent and narrowed rather than voided where permitted.
12. Third-party Indemnification
To the fullest extent permitted by law, Student shall indemnify, defend, and hold harmless the Academy Parties from third-party claims, demands, actions, proceedings, judgments, settlements, damages, fines, penalties, costs, and reasonable attorneys’ fees arising from or relating to:
This Section does not require Student to indemnify an Academy Party to the extent a claim is finally determined to have been caused by that Academy Party’s gross negligence, reckless or willful misconduct, intentional wrongdoing, or fraud, or to the extent indemnification is prohibited by law. The Academy will provide reasonably prompt notice of a covered claim. Student may not settle a claim in a manner that admits wrongdoing by, imposes nonmonetary obligations on, or fails to fully release an Academy Party without the Academy’s prior written consent. The Academy may participate through counsel of its choice at its own expense, except where a conflict, failure to defend, or other circumstance permits recovery of that expense under applicable law.
- Student’s clinical services, patient care, product or device use, teaching, supervision, delegation, advertising, representations, or complication management;
- Student’s violation of law, licensing or board requirements, facility policy, professional standards, privacy obligations, or a third party’s rights;
- Student’s breach of this Agreement or inaccurate credential representation; or
- Student’s unauthorized recording, reproduction, distribution, public display, account sharing, or other misuse of Clinical Content.
This Section does not require Student to indemnify an Academy Party to the extent a claim is finally determined to have been caused by that Academy Party’s gross negligence, reckless or willful misconduct, intentional wrongdoing, or fraud, or to the extent indemnification is prohibited by law. The Academy will provide reasonably prompt notice of a covered claim. Student may not settle a claim in a manner that admits wrongdoing by, imposes nonmonetary obligations on, or fails to fully release an Academy Party without the Academy’s prior written consent. The Academy may participate through counsel of its choice at its own expense, except where a conflict, failure to defend, or other circumstance permits recovery of that expense under applicable law.
13. No Reliance on Examples, Outcomes, or Product References
Cases, images, demonstrations, outcomes, opinions, and product references are illustrative and patient-specific. They do not promise or predict any result. Student has not relied on any guarantee of safety, effectiveness, complication avoidance, professional advancement, income, patient outcome, or regulatory acceptance. Product names and third-party materials remain the property of their respective owners; discussion does not imply manufacturer sponsorship or endorsement unless expressly stated.
14. Relationship to Other Academy Terms
This Agreement supplements the Academy’s Terms and Conditions, Refund, Cancellation, and Course Access Policy, Privacy Policy, product page, and any course-specific written terms. If there is a conflict, this Agreement controls only regarding clinical-risk acknowledgment, assumption of professional responsibility and risk, the limited release, covenant not to sue, and third-party indemnification. The other Academy terms control in all other respects. No oral statement or informal communication modifies this Agreement.
15. Governing Law and Dispute Process
This Agreement is governed by Massachusetts law, without regard to conflict-of-law principles, except to the extent mandatory law requires otherwise. Any enforceable arbitration, forum, venue, or dispute-resolution provision in the Academy’s Terms and Conditions applies to this Agreement. If the Terms and Conditions contain no applicable forum provision, Student consents to exclusive jurisdiction in the state courts located in Plymouth County, Massachusetts, and the United States District Court for the District of Massachusetts, subject to any mandatory nonwaivable law.
16. Checkbox Acceptance, Attribution, and Records
Student agrees to transact electronically. By voluntarily checking the required, unchecked-by-default box at checkout and then completing the purchase, Student manifests Student’s intent to be legally bound by the complete Agreement and adopts the checkbox act as Student’s electronic signature and affirmative acceptance. No handwritten signature, typed-name signature, initials, scrolling certification, or separate electronic-signature process is required for acceptance.
Student agrees that platform and transaction records—including the Agreement title, effective date and version; exact checkbox language presented; purchaser and account identifiers; course or bundle; order or transaction identifier; date and time; checkbox event; payment event; IP address, device, browser, and access records to the extent collected—may be used to attribute and prove acceptance. The Academy may retain and reproduce this Agreement and those records electronically. The then-current Agreement must remain reasonably available for review before purchase and afterward through the Academy website or student-access area. Upon request, the Academy will provide an electronic copy of the version associated with Student’s purchase.
17. Construction, Severability, Waiver, and Survival
Headings are for convenience only. “Including” means “including without limitation.” If any provision is invalid or unenforceable, it shall be severed or narrowed to the minimum extent necessary, and the remaining provisions remain effective. A failure to enforce a provision is not a waiver. Sections that by their nature should survive—including professional responsibility, assumption of risk, release, covenant not to sue, indemnification, governing law, records, and construction—survive expiration or termination of access.
18. Student Acknowledgement and Voluntary Agreement
- I have had a reasonable opportunity to review this entire Agreement before checking the required checkout box and to ask questions or consult independent legal, licensing, insurance, or clinical advisors.
- I understand the nature and purpose of this Agreement and am not relying on a statement that contradicts it.
- I understand that some Clinical Content may be off-label, investigational, advanced, or restricted in my jurisdiction.
- I understand that online education and a certificate do not establish clinical competency or replace hands-on training.
- I will not perform a demonstrated procedure based solely on Academy content.
- I accept independent responsibility for my licensure, scope, training, patient care, informed consent, documentation, insurance, and complication management.
- I understand the serious, irreversible, and potentially fatal risks described above.
- I knowingly and voluntarily agree to the assumption of responsibility and risk, limited release, covenant not to sue, and third-party indemnification provisions.
- I am at least 18 years old, have authority to enter into this Agreement, and understand that access will not be provided if I do not agree.
19. Company Information
MBR Hunt LLC d/b/a The French Academy of Advanced Aesthetics
MBR Hunt LLC d/b/a The French NP
185 Lincoln Street, Suite 105
Hingham, Massachusetts 02043, USA
Email: info@thefrenchnp.com
Last updated: August 1, 2026
Copyright © 2026


